8-K
filed August 3, 2026, 4:48 PM ET
CIK 0001497130
M&A
confidence high
sentiment neutral
materiality 0.75
Nano Mobile Healthcare to acquire Neptune Engineering in stock-for-stock deal; new leadership appointed
Nano Mobile Healthcare, Inc.
- Acquires Neptune Engineering (Marine) Ltd, a Hong Kong marine and diving engineering contractor, for 20M shares of VNTH common stock.
- Neptune shareholders receive 20M shares (post-restructuring) for 100% of Neptune; Neptune becomes wholly-owned subsidiary.
- New directors: Cheng Chung Sing (Chairman), Cheng Chung Yu (CEO), Angel Yik (CFO); Roy Watson remains President.
- Neptune's FY2025 revenue HK$9.07M (~$1.16M), net profit HK$862,586 (~$110K); unsecured loans HK$4.04M.
- Closing expected on third business day after conditions satisfied; shares restricted under Regulation S.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Angel Yik was elected as Director and Secretary, as Chief Financial Officer (CFO) at Nano Mobile Healthcare, Inc..
- Action
- elected
- Role
- Director and Secretary, as Chief Financial Officer (CFO)
Exact text from the filing
Angel Yik as Director and Secretary, as Chief Financial Officer (CFO)
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Cheng Chung Yu was elected as Director and Chief Executive Officer at Nano Mobile Healthcare, Inc..
- Action
- elected
- Role
- Director and Chief Executive Officer
Exact text from the filing
Cheng Chung Yu (Neptune (HK)) as Director and Chief Executive Officer CEO
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Cheng Chung Sing was elected as Director, Chairman of the Board at Nano Mobile Healthcare, Inc..
- Action
- elected
- Role
- Director, Chairman of the Board
Exact text from the filing
Cheng Chung Sing (Byron) as Director, Chairman of the Board
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.